Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma

Cancer Immunology, Immunotherapy

Volumn 58, Issue 7, 2009, Pages 1117-1128

  Diaz, Y ^a   Gonzalez, A ^a   Lopez, A ^a   Perez, R ^a   Vazquez, A M ^a   Montero, E ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

Angiogenesis; Anti idiotype monoclonal antibody; Apoptosis; Cancer vaccine; Lung carcinoma metastases; NeuGc containing ganglioside

Indexed keywords

ALUMINUM HYDROXIDE; CANCER VACCINE; GANGLIOSIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1E10; SULFATIDE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CANCER IMMUNIZATION; CANCER MODEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LEWIS CARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; LUNG NODULE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; T LYMPHOCYTE; THERAPY EFFECT; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; FEMALE; GANGLIOSIDES; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL;

EID: 67349136455     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0634-y     Document Type: Article

References (55)

1. NK Jerne 1974 Towards a network theory of the immune system Ann Immunol (Paris) 125C 1-2 373 389
2. PL Dunn CA Johnson JM Styles SS Pease CJ Dean 1987 Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge Immunology 60 2 181 186 (Pubitemid 17007365)
3. T Jinnohara M Tsujisaki S Sasaki Y Hinoda M Taniguchi K Imai 1998 Anti-tumor effect of internal image bearing anti-idiotypic monoclonal antibody in relation to GM3 ganglioside Int J Cancer 76 3 345 353 (Pubitemid 28282933)
4. GW Denton LG Durrant JD Hardcastle EB Austin HF Sewell RA Robins 1994 Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody Int J Cancer 57 1 10 14 (Pubitemid 24117092)
5. LG Durrant M Doran EB Austin RA Robins 1995 Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours Int J Cancer 61 1 62 66
6. J Fagerberg M Steinitz H Wigzell P Askelof H Mellstedt 1995 Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients Proc Natl Acad Sci USA 92 11 4773 4777
7. LG Durrant DJ Buckley RA Robins I Spendlove 2000 105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses Int J Cancer 85 1 87 92
8. S Reinartz S Kohler H Schlebusch K Krista P Giffels K Renke J Huober V Mobus R Kreienberg A DuBois P Sabbatini U Wagner 2004 Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II) Clin Cancer Res 10 5 1580 1587 (Pubitemid 38435546)
9. AM Vazquez M Alfonso B Lanne KA Karlsson A Carr O Barroso LE Fernandez E Rengifo ME Lanio C Alvarez 1995 Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids Hybridoma 14 6 551 556 (Pubitemid 26028517)
10. AM Vazquez MR Gabri AM Hernandez DF Alonso I Beausoleil DE Gomez R Perez 2000 Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides Oncol Rep 7 4 751 756
11. M Alfonso A Diaz AM Hernandez A Perez E Rodriguez R Bitton R Perez AM Vazquez 2002 An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients J Immunol 168 5 2523 2529 (Pubitemid 34171859)
12. E Neninger RM Diaz A de la Torre R Rives A Diaz G Saurez MR Gabri DF Alonso B Wilkinson AM Alfonso T Combet R Perez AM Vazquez 2007 Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial Cancer Biol Ther 6 2 145 150 (Pubitemid 46641614)
13. AM Vazquez A Perez AM Hernandez A Macias M Alfonso G Bombino R Perez 1998 Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody Hybridoma 17 6 527 534 (Pubitemid 29024638)
14. AM Hernandez M Rodriguez A Lopez-Requena I Beausoleil R Perez AM Vazquez 2005 Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti-idiotype monoclonal antibody: a self versus non-self-matter Immunobiology 210 1 11 21 (Pubitemid 40862456)
15. A Diaz M Alfonso R Alonso G Saurez M Troche M Catala RM Diaz R Perez AM Vazquez 2003 Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides Clin Immunol 107 2 80 89 (Pubitemid 36579371)
16. HH Chou H Takematsu S Diaz J Iber E Nickerson KL Wright EA Muchmore DL Nelson ST Warren A Varki 1998 A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence Proc Natl Acad Sci USA 95 20 11751 11756 (Pubitemid 28460486)
17. RW Ledeen RK Yu 1982 Gangliosides: structure, isolation, and analysis Methods Enzymol 83 139 191
18. MV Olson A Varki 2003 Sequencing the chimpanzee genome: insights into human evolution and disease Nat Rev Genet 4 1 20 28 (Pubitemid 36043212)
19. CL Stults CC Sweeley BA Macher 1989 Glycosphingolipids: structure, biological source, and properties Methods Enzymol 179 167 214 (Pubitemid 20044395)
20. L Eisenbach N Hollander L Greenfeld H Yakor S Segal M Feldman 1984 The differential expression of H-2 K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells Int J Cancer 34 4 567 573 (Pubitemid 14014125)
21. M Alfonso AM Vazquez A Carr T Haerslev LE Fernandez ME Lanio C Alvarez J Zeuthen R Perez 1995 T cell-independent B cell response to self- monosialogangliosides: primary response monoclonal antibodies Hybridoma 14 3 209 216
22. RS Kerbel 2000 Tumor angiogenesis: past, present and the near future Carcinogenesis 21 3 505 515 (Pubitemid 30137936)
23. KG Kohlgraf AJ Gawron M Higashi ML VanLith X Shen TC Caffrey JM Anderson MA Hollingsworth 2004 Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1) Cancer Immunol Immunother 53 12 1068 1084 (Pubitemid 39506396)
24. JY Liu YQ Wei L Yang X Zhao L Tian JM Hou T Niu F Liu Y Jiang B Hu Y Wu JM Su YY Lou QM He YJ Wen JL Yang B Kan YQ Mao F Luo F Peng 2003 Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 Blood 102 5 1815 1823 (Pubitemid 37022578)
25. B Birebent E Mitchell N Akis W Li R Somasundaram E Purev D Hoey M Mastrangelo H Maguire DT Harris S Nair D Cai T Zhang DM Herlyn 2003 Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients Vaccine 21 15 1601 1612 (Pubitemid 36287592)
26. MW Pride S Shuey A Grillo-Lopez G Braslawsky M Ross SS Legha O Eton A Buzaid C Ioannides JL Murray 1998 Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen Clin Cancer Res 4 10 2363 2370 (Pubitemid 28477900)
27. U Wagner S Kohler S Reinartz P Giffels J Huober K Renke H Schlebusch HJ Biersack V Mobus R Kreienberg T Bauknecht D Krebs D Wallwiener 2001 Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment Clin Cancer Res 7 5 1154 1162 (Pubitemid 32708665)
28. PO Livingston G Ragupathi 1997 Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans Cancer Immunol Immunother 45 1 10 19 (Pubitemid 27444465)
29. PB Chapman 2003 Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody Curr Opin Investig Drugs 4 6 710 715 (Pubitemid 36916712)
30. GY Ishioka AG Lamont D Thomson N Bulbow FC Gaeta A Sette HM Grey 1992 MHC interaction and T cell recognition of carbohydrates and glycopeptides J Immunol 148 8 2446 2451
31. A Shamshiev A Donda I Carena L Mori L Kappos G De Libero 1999 Self glycolipids as T-cell autoantigens Eur J Immunol 29 5 1667 1675 (Pubitemid 29224472)
32. DY Wu NH Segal S Sidobre M Kronenberg PB Chapman 2003 Cross-presentation of disialoganglioside GD3 to natural killer T cells J Exp Med 198 1 173 181 (Pubitemid 36870197)
33. Z Mazorra C Mesa A Fernandez LE Fernandez 2008 Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge Cancer Immunol Immunother 57 12 1771 1780
34. MD Guthmann MA Castro G Cinat C Venier L Koliren RJ Bitton AM Vazquez L Fainboim 2006 Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients J Immunother 29 2 215 223 (Pubitemid 43756097)
35. R Sasisekharan Z Shriver G Venkataraman U Narayanasami 2002 Roles of heparan-sulphate glycosaminoglycans in cancer Nat Rev Cancer 2 7 521 528 (Pubitemid 37328933)
36. D Rajotte W Arap M Hagedorn E Koivunen R Pasqualini E Ruoslahti 1998 Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J Clin Invest 102 2 430 437 (Pubitemid 28335203)
37. A Perez ES Mier NS Vispo AM Vazquez R Perez Rodriguez 2002 A monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells Mol Immunol 39 1-2 103 112 (Pubitemid 35245388)
38. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 (Pubitemid 30046295)
39. MB Atkins M Hidalgo WM Stadler TF Logan JP Dutcher GR Hudes Y Park SH Liou B Marshall JP Boni G Dukart ML Sherman 2004 Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma J Clin Oncol 22 5 909 918 (Pubitemid 41103603)
40. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 5 1011 1027 (Pubitemid 46202320)
41. RJ Klasa AM Gillum RE Klem SR Frankel 2002 Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment Antisense Nucleic Acid Drug Dev 12 3 193 213
42. BI Rini EJ Small 2005 Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma J Clin Oncol 23 5 1028 1043 (Pubitemid 46202321)
43. S Amin RA Robins CA Maxwell-Armstrong JH Scholefield LG Durrant 2000 Vaccine-induced apoptosis: a novel clinical trial end point? Cancer Res 60 12 3132 3136 (Pubitemid 30407905)
44. AK Nowak RA Lake AL Marzo B Scott WR Heath EJ Collins JA Frelinger BW Robinson 2003 Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells J Immunol 170 10 4905 4913 (Pubitemid 36554719)
45. L Roque-Navarro K Chakrabandhu J de Leon S Rodriguez C Toledo A Carr CM de Acosta AO Hueber R Perez 2008 Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity Mol Cancer Ther 7 7 2033 2041
46. T Crombet-Ramos J Rak R Perez A Viloria-Petit 2002 Antiproliferative, antiangiogenic and proapoptotic activity of h-R3: a humanized anti-EGFR antibody Int J Cancer 101 6 567 575
47. YD Jung PF Mansfield M Akagi A Takeda W Liu CD Bucana DJ Hicklin LM Ellis 2002 Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model Eur J Cancer 38 8 1133 1140 (Pubitemid 34468020)
48. + T cells directly induces apoptosis of mouse hepatocellular carcinoma J Hepatol 45 5 662 672 (Pubitemid 44488582)
49. + T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity J Immunol 169 2 809 817 (Pubitemid 34753437)
50. MH Manjili 2007 Come forth 1E10 anti-idiotype vaccine: delivering the promise to immunotherapy of small cell lung cancer Cancer Biol Ther 6 2 151 152 (Pubitemid 46641615)
51. S Alfonso RM Diaz A de la Torre E Santiesteban F Aguirre K Perez JL Rodriguez MD Barroso AM Hernandez D Toledo MR Gabri DF Alonso C Viada RE Gomez E Suarez AM Vazquez R Perez AE Macias 2007 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients Cancer Biol Ther 6 12 1847 1852
52. G Gasparini R Longo M Fanelli BA Teicher 2005 Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions J Clin Oncol 23 6 1295 1311 (Pubitemid 46202288)
53. MD Pegram A Lipton DF Hayes BL Weber JM Baselga D Tripathy D Baly SA Baughman T Twaddell JA Glaspy DJ Slamon 1998 Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment J Clin Oncol 16 8 2659 2671 (Pubitemid 28363029)
54. Teicher BA (1999) Potentiation of cytotoxic cancer therapies by antiangiogenic agents. Humana Press Inc, Totowa
55. GF Woude GJ Kelloff RW Ruddon HM Koo CC Sigman JC Barrett RW Day AP Dicker RS Kerbel DR Parkinson WJ Slichenmyer 2004 Reanalysis of cancer drugs: old drugs, new tricks Clin Cancer Res 10 11 3897 3907 (Pubitemid 38697626)